Position in ILMN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$703
+$210 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#906
of 932 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Inspire Investing, LLC holds $34,317,016 across 18 Diagnostics & Research names. ILMN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
18,347 | $9,658,594 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
38,705 | $7,478,580 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
3,486 | $4,453,399 | |
| 4 | ICLR |
Icon PLC
|
17,182 | $2,984,685 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
5,358 | $2,837,543 | |
| 6 | LH |
Labcorp Holdings Inc.
|
4,192 | $1,173,760 | |
| 7 | GH |
Guardant Health, Inc.
|
6,196 | $929,585 | |
| 8 | TWST |
Twist Bioscience Corp
|
6,862 | $705,962 |
All Filings in ILMN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $703 | 4 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $493 | 4 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $524 | 4 | Shares | Sole | 2026-02-17 | |
| 2021-12-31 | $303,210 | 797 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,460,791 | 18,394 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $4,925,642 | 10,409 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,527,206 | 9,184 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $2,693,230 | 7,279 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,884,460 | 6,097 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,387,275 | 6,446 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,159,940 | 4,247 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||